Login to Your Account



Esperion In Suit Against Sacane, Seeks To Recover Related Profits

By Aaron Lorenzo


Wednesday, August 27, 2003
It's not common for a company to sue its largest shareholder. But Esperion Therapeutics Inc. finds itself in that position after revealing late Monday its litigation against Scott Sacane and hedge funds he manages. Just four weeks ago, Esperion discovered that Sacane and his related entities had acquired about a third of its outstanding shares. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription